Positron emission tomography(PET)is a powerful noninvasive imaging tool for phenotyping patients at risk of or with known coronary artery disease(CAD).One of the key advantages over other imaging modalities is its uni...Positron emission tomography(PET)is a powerful noninvasive imaging tool for phenotyping patients at risk of or with known coronary artery disease(CAD).One of the key advantages over other imaging modalities is its unique ability to quantify physiologic processes,including myocardial blood fl ow(in milliliters per minute per gram of myocardium),metabolism,and cardiac receptors,and its high sensitivity for delineating and quantifying molecular targets in vivo using targeted imaging probes.Cardiac PET/CT offers opportunity for a comprehensive noninvasive evaluation of the consequences of atherosclerosis in the coronary arteries and the myocardium.展开更多
Ovarian cancer (OC) is the most fatal gynecological malignancy, and identifying reliable prognostic indicators can help guide therapeutic treatment. Various tumor marker-guided treatment regimens can considerably impr...Ovarian cancer (OC) is the most fatal gynecological malignancy, and identifying reliable prognostic indicators can help guide therapeutic treatment. Various tumor marker-guided treatment regimens can considerably improve patient prognosis with a better understanding of the molecular underpinnings of ovarian cancer recurrence and metastasis. Fluorine-18-fluorodeoxyglucose Positron emission tomography/computed tomography (18F-FDG PET/CT) is a molecular imaging tool that provides anatomical and functional information about the tumor, and its volume-based metabolic parameters allow for quantifiable observation of ovarian cancer recurrence, prognosis, and therapeutic efficacy. The combined utilization of serological and radiologic markers has been found to provide increased clinical benefit. This article reviewed the predictive value of serum tumor markers and 18F-FDG PET/CT volumetric metabolic parameters for the prognosis of patients with ovarian cancer.展开更多
Introduction:Fluorine-18 fluorodeoxyglucose(18F-FDG)positron emission tomography/computed tomography(PET/CT)is a powerful tool for monitoring the response of diffuse large B-cell lymphoma(DLBCL)to therapy,but the crit...Introduction:Fluorine-18 fluorodeoxyglucose(18F-FDG)positron emission tomography/computed tomography(PET/CT)is a powerful tool for monitoring the response of diffuse large B-cell lymphoma(DLBCL)to therapy,but the criteria to interpret PET/CT results remain under debate.We investigated the value of post-treatment PET/CT in predicting the prognosis of DLBCL patients when interpreted according to qualitative visual trichotomous assessment(QVTA)criteria compared with the Deauvil e criteria.Methods:In this retrospective study,final PET/CT scans of DLBCL patients treated with rituximab-based regimens between October 2005 and November 2010 were interpreted using the Deauvil e and QVTA criteria.Survival curves were estimated using Kaplan-Meier analysis and compared using the log-rank test.Results:A total of 253 patients were enrol ed.The interpretation according to the Deauvil e criteria revealed that 181patients had negative PET/CT scan results and 72 had positive results.The 3 year overal survival(OS)rate was significantly higher in patients with negative scan results than in those with positive results(91.6%vs.57.5%,P<0.001).The72 patients with positive scan results according to the Deauville criteria were divided into two groups by the interpretation according to the QVTA criteria:29 had indeterminate results,and 43 had positive results.The 3 year OS rate was significantly higher in patients with indeterminate scan results than in those with positive results(91.2%vs.33.5%,P<0.001)but was similar between patients with negative and indeterminate scan results(91.6%vs.91.2%,P=0.921).Conclusions:Compared with the Deauvil e criteria,using the QVTA criteria for interpreting post-treatment PET/CT scans of DLBCL patients is likely to reduce the number of false positive results.The QVTA criteria are feasible for therapeutic outcome evaluation and can be used to guide risk-adapted therapy.展开更多
Objective To investigate relationship between prognosis of infant spasm and electroencephalogram(EEG) and head CT.Method 47 infants underwent EEG and head CT.Follow up was performed to compare the prognosis during dif...Objective To investigate relationship between prognosis of infant spasm and electroencephalogram(EEG) and head CT.Method 47 infants underwent EEG and head CT.Follow up was performed to compare the prognosis during different periods.Result Among 31 infants with abnormal head CT,2 infants were cured,17 were improved and effective rate was 61.3%. Among 16 patients with normal head CT,6 were cured,8 were improved,and effective rate was 87.5%. Among 34 infants with high rhythm disorder,8 were cured,21 were improved,effective rate was 85.29%. For 13 infants with abnormal EEG of other types,no infants were cured,4 were improved,and effective rate was 30.8%.Conclusion Changed head CT not various EEG has no significant effect on prognosis of infant spasm(P >0.05).Prognosis is favorable in infants with high rhythm disorder(P<0.01).展开更多
文摘Positron emission tomography(PET)is a powerful noninvasive imaging tool for phenotyping patients at risk of or with known coronary artery disease(CAD).One of the key advantages over other imaging modalities is its unique ability to quantify physiologic processes,including myocardial blood fl ow(in milliliters per minute per gram of myocardium),metabolism,and cardiac receptors,and its high sensitivity for delineating and quantifying molecular targets in vivo using targeted imaging probes.Cardiac PET/CT offers opportunity for a comprehensive noninvasive evaluation of the consequences of atherosclerosis in the coronary arteries and the myocardium.
文摘Ovarian cancer (OC) is the most fatal gynecological malignancy, and identifying reliable prognostic indicators can help guide therapeutic treatment. Various tumor marker-guided treatment regimens can considerably improve patient prognosis with a better understanding of the molecular underpinnings of ovarian cancer recurrence and metastasis. Fluorine-18-fluorodeoxyglucose Positron emission tomography/computed tomography (18F-FDG PET/CT) is a molecular imaging tool that provides anatomical and functional information about the tumor, and its volume-based metabolic parameters allow for quantifiable observation of ovarian cancer recurrence, prognosis, and therapeutic efficacy. The combined utilization of serological and radiologic markers has been found to provide increased clinical benefit. This article reviewed the predictive value of serum tumor markers and 18F-FDG PET/CT volumetric metabolic parameters for the prognosis of patients with ovarian cancer.
文摘Introduction:Fluorine-18 fluorodeoxyglucose(18F-FDG)positron emission tomography/computed tomography(PET/CT)is a powerful tool for monitoring the response of diffuse large B-cell lymphoma(DLBCL)to therapy,but the criteria to interpret PET/CT results remain under debate.We investigated the value of post-treatment PET/CT in predicting the prognosis of DLBCL patients when interpreted according to qualitative visual trichotomous assessment(QVTA)criteria compared with the Deauvil e criteria.Methods:In this retrospective study,final PET/CT scans of DLBCL patients treated with rituximab-based regimens between October 2005 and November 2010 were interpreted using the Deauvil e and QVTA criteria.Survival curves were estimated using Kaplan-Meier analysis and compared using the log-rank test.Results:A total of 253 patients were enrol ed.The interpretation according to the Deauvil e criteria revealed that 181patients had negative PET/CT scan results and 72 had positive results.The 3 year overal survival(OS)rate was significantly higher in patients with negative scan results than in those with positive results(91.6%vs.57.5%,P<0.001).The72 patients with positive scan results according to the Deauville criteria were divided into two groups by the interpretation according to the QVTA criteria:29 had indeterminate results,and 43 had positive results.The 3 year OS rate was significantly higher in patients with indeterminate scan results than in those with positive results(91.2%vs.33.5%,P<0.001)but was similar between patients with negative and indeterminate scan results(91.6%vs.91.2%,P=0.921).Conclusions:Compared with the Deauvil e criteria,using the QVTA criteria for interpreting post-treatment PET/CT scans of DLBCL patients is likely to reduce the number of false positive results.The QVTA criteria are feasible for therapeutic outcome evaluation and can be used to guide risk-adapted therapy.
文摘Objective To investigate relationship between prognosis of infant spasm and electroencephalogram(EEG) and head CT.Method 47 infants underwent EEG and head CT.Follow up was performed to compare the prognosis during different periods.Result Among 31 infants with abnormal head CT,2 infants were cured,17 were improved and effective rate was 61.3%. Among 16 patients with normal head CT,6 were cured,8 were improved,and effective rate was 87.5%. Among 34 infants with high rhythm disorder,8 were cured,21 were improved,effective rate was 85.29%. For 13 infants with abnormal EEG of other types,no infants were cured,4 were improved,and effective rate was 30.8%.Conclusion Changed head CT not various EEG has no significant effect on prognosis of infant spasm(P >0.05).Prognosis is favorable in infants with high rhythm disorder(P<0.01).